ADVANCED PRE-CLINICAL TESTING THROUGH TISSUE ENGINEERING

DOING AWAY WITH ANIMAL STUDIES LIMITATIONS

Conventional pre-clinical testing for drugs and medical devices is a complex and time-consuming process, with animal test outcomes not directly linkable to clinical human test results, due to the huge gap in physiological conditions. The regulatory approval of drugs needs repeatable and reliable test results, but no amount of animal testing will ever be able to fully predict the human pathophysiological response.

1LAB’s team of highly trained scientists have developed novel and scientifically-proved proprietary methods to bridge the gap between pre-clinical animal testing and  human testing through artificial human tissue generation. This gives 1LAB’s clients a powerful tool for decreasing the uncertainty in medical devices and drug development in the pre-clinical phase.

1LAB is able to create accurate vessels and skin models, as well as other organ models. This in-vitro tissue engineering approach gives its clients a more useful, satisfying, and robust result.